Smart Asthma Monitoring Device Market Analysis

  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Smart Asthma Monitoring Device Market Analysis

End Users (Hospitals, Specialty Clinics, Home Care)

The hospital segment is expected to hold 40% share of the global smart asthma monitoring device market by the end of 2037. This can be attributed to the increasing demand for hospital-based environments for the treatment of acute serious asthmatic problems and also owing to the high incorporation of smart inhalers for instance dry powdered inhalers and metered dose inhalers.

Moreover, the accessibility of healthcare professionals who offer multiple guidance on the successful handling of monitoring devices is expected to boost the growth of the segment.

Product (Wearable Monitors, Smart Inhalers, Breath Analyzer, Nebulizers)

Smart asthma monitoring device market from the smart inhaler segment is anticipated to observe the largest revenue in the forecast timeframe. With the surge in the integration of smart inhalers in emerging economies, and the escalating demand for smart inhalers that can accurately record the time & monitor adherence and can be digitally connected to the app.

Our in-depth analysis of the global market includes the following segments:

         Product

  • Wearable Monitors
  • Smart Inhalers
  • Breath Analyzer
  • Nebulizers

       Device

  • Cloud-based
  • AI-based

       End User

  • Hospitals
  • Specialty Clinics
  • Home Care
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.

The smart asthma monitoring device market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of asthma, backed by rapid urbanization will drive the market growth.

North America industry is likely to hold largest revenue share of 38% by 2037, driven by high incidence of asthma in developed nations.

The major players in the market are Astellas Pharma Inc., Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, BioTelemetry, Inc., Health Care Originals Inc., Reciprocal Labs Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample